Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Zealand Pharma - Filing #1382857

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
14,617,000 EUR
14,155,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
223,454,000 EUR
346,033,000 EUR
Current assets
1,316,352,000 EUR
1,721,596,000 EUR
Non-current liabilities
528,404,000 EUR
805,509,000 EUR
Current liabilities
195,491,000 EUR
334,317,000 EUR
Revenue
103,986,000 EUR
108,546,000 EUR
192,001,000 EUR
Profit (loss) from continuing operations
965,610,000 EUR
754,938,000 EUR
668,713,000 EUR
Profit (loss) from discontinued operations
236,525,000 EUR
263,211,000 EUR
178,016,000 EUR
Profit (loss)
0 EUR
1,202,135,000 EUR
1,202,135,000 EUR
0 EUR
0 EUR
1,018,149,000 EUR
0 EUR
1,018,149,000 EUR
0 EUR
846,729,000 EUR
0 EUR
846,729,000 EUR
Other comprehensive income
0 EUR
0 EUR
462,000 EUR
462,000 EUR
5,178,000 EUR
0 EUR
0 EUR
5,178,000 EUR
0 EUR
8,977,000 EUR
8,977,000 EUR
0 EUR
Comprehensive income
1,201,673,000 EUR
1,012,971,000 EUR
837,752,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.